about
Radiotherapy of Ductal Carcinoma In SituEfficacy and toxicity of chemoradiation in patients with anal cancer--a retrospective analysis.Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapyDEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences.Whole brain helical Tomotherapy with integrated boost for brain metastases in patients with malignant melanoma-a randomized trial.Intrafractional dose variation and beam configuration in carbon ion radiotherapy for esophageal cancer.Current controversies in radiotherapy for breast cancer.Situation of young radiation oncologists, medical physicists and radiation biologists in German-speaking countries : Results from a web-based survey of the Young DEGRO working group.Minor cartilage collagens type IX and XI are expressed during embryonic stem cell-derived in vitro chondrogenesis.Simvastatin modulates mouse embryonic stem cell-derived chondrogenesis in vitro.[Neoadjuvant short-term radiotherapy followed by FOLFOX chemotherapy : No standard treatment for rectal cancer].[Omission of adjuvant radiotherapy in ductal carcinoma in situ : 12 year-results of the ECOG-ACRIN E5194-trial].Prospective phase-II-study evaluating postoperative radiotherapy of cervical and endometrial cancer patients using protons - the APROVE-trial.Quality of training in radiation oncology in Germany: where do we stand? : Results from a 2016/2017 survey performed by the working group "young DEGRO" of the German society of radiation oncology (DEGRO).Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review.[Radiochemotherapy improves failure-free survival in stage III endometrial cancer : Final results of the PORTEC-3 trial].[Determination of prognosis using gene expression analyses: Consequences for the indication for radiotherapy?].Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatmentHeart toxicity from breast cancer radiotherapy : Current findings, assessment, and preventionWhole-brain helical tomotherapy with integrated boost for brain metastases in patients with malignant melanoma - final results of the BRAIN-RT trial.[Regional nodal irradiation in early-stage breast cancer with 0-3 positive nodes][Accelerated partial breast irradiation using interstitial multicatheter brachytherapy: A valid treatment option for breast cancer patients with a low-risk profile?][Prognostic factors for locoregional recurrence after neoadjuvant chemotherapy. Results of a combined analysis from NSABP B-18 and B-27][Radiotherapeutic concepts in cancer of unknown primary site][Cardiotoxicity of trastuzumab in the adjuvant treatment of breast cancer patients : Results of the NCCTG N9831 trial]Postoperative radiotherapy of patients with thymic epithelial tumors (TET): a retrospective analysis of outcome and toxicityMalignant progression of a histone H3.3 K27M-mutated spinal pilocytic astrocytoma in an adult[Whole- or partial-breast radiotherapy after 5 years from a patient perspective: longitudinal analysis of the IMPORT LOW (CRUK/06/003) phase III trial]Second breast conserving therapy after ipsilateral breast tumor recurrence - a 10-year experience of re-irradiationAGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019[Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study]Comment to Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease; an individual patient data analysis of three clinical trialsProduction of a Dibrominated Aromatic Secondary Metabolite by a Planctomycete Implies Complex Interaction with a Macroalgal HostStereotactic body radiotherapy for ventricular tachycardia (cardiac radiosurgery) : First-in-patient treatment in Germany[Unexpectedly high mortality after surgical liver interventions in Germany]Preoperative radiotherapy: A paradigm shift in the treatment of breast cancer? A review of literatureProspective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) TrialValidation of a Nomogram Predicting Non-Sentinel Lymph Node Metastases among Patients with Breast Cancer after Primary Systemic Therapy - a transSENTINA Substudy[Radiotherapy versus transoral robotic surgery for primary treatment of oropharyngeal squamous cell carcinoma: randomisation decides]
P50
Q26776277-3AAA1819-7FBE-4BD4-924E-F5F635A43DE9Q33646367-AA831BB2-87A3-4D7A-90A8-DCE50B3E41E5Q35835137-A43B4026-4C76-4C97-A1EA-AF0EA40509EEQ36804205-85E5E274-2429-45E1-8C19-985C20FC413EQ37276126-0EB726BF-B2A9-4FAA-B00F-4F80EA245679Q37414605-0C6C1A0C-FBD5-491F-8A69-122A16E88A79Q37602477-8D62BCB1-3D2A-40B8-AFEB-2183C56DF01CQ38848634-EE819901-67B5-4B4F-B2E1-64A804399A00Q39283288-C11FCC3C-F20D-47A5-8C37-26A51383E994Q39318373-BCAF4B3E-38CE-484E-A9FF-0D3D155500C9Q40531553-8CA2F583-1BC9-45C7-9EC9-66DCEE81600FQ40799838-B2329B69-3173-40F8-8C74-64A892D8F806Q47140613-3CC22958-7D52-43AB-AE38-2D9EB697C27DQ47724340-2DDAB75C-2C55-4909-9BAE-43B87F36CB5DQ47898194-D9D978E7-7869-403A-AE78-3EC1A0A7E23FQ50110509-4F1FA821-0474-4802-B2AA-03CE81324704Q55034874-F3E0353B-8080-4B9A-93EA-FF16814E94CCQ57107280-42D7F9D0-3BEA-4FAB-A281-62CAB26E7128Q57477384-8F1BC963-F0F4-4A78-B58D-05F634C55CEBQ64946218-7EBC1A96-CB09-4525-A2CF-93DBDE97BA87Q86168103-2F67CFCA-67D7-4BF9-AB35-608DEBAC5372Q86858786-999479AB-9712-4CEF-B32C-77432505EF02Q86920968-BCD3D486-8EC9-48B4-9C33-4AFD6388F53AQ86949343-118951EE-B0D6-43E2-80FB-D8E99660545BQ87130932-539610BA-1559-44E7-90CA-9C74A7E3FA97Q87657970-82FAF17A-D80E-44B9-BA45-0C5D9A122D59Q88878460-DCFAB6A9-5D79-48B5-8B1C-B0A8B09C5A14Q90004389-E04DC4B0-51DF-4DBF-BF61-8BB79AB1FFDDQ90115519-51BF80E5-50CB-498D-AE5D-56B696AA6F6FQ90318502-C1442682-837A-4429-B9B2-895C134883BAQ90318508-68E85F8E-33C4-40DC-9F10-6BAD7CD10EB9Q90864742-E7A0D605-A28C-4F5C-A69D-CAE24FB51A24Q90895147-F6E8CF9C-A92F-4C4F-A2CB-7DD23B1532A1Q90903548-925083B6-2491-4833-A7A6-CD4285D8D02EQ91048254-A725D637-DD09-4F94-97C4-74C22A9CC7D6Q91303233-FA05CC7B-191D-44D4-BFCC-146EB350DB4BQ91610353-17835CC7-544C-433F-829A-940921F803E9Q91666373-14D2E41E-1BDB-4448-A8B6-997C9589CBA5Q91872273-F31060E8-05D9-4338-86D7-20E56D86BA8CQ91941725-D67ED553-CB9D-4C72-A687-0E9F18051633
P50
description
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
David Krug
@ast
David Krug
@en
David Krug
@es
David Krug
@nl
type
label
David Krug
@ast
David Krug
@en
David Krug
@es
David Krug
@nl
prefLabel
David Krug
@ast
David Krug
@en
David Krug
@es
David Krug
@nl
P214
P106
P21
P214
P31
P496
0000-0001-8811-5416
P735
P7859
viaf-311734095